Palliative chemotherapy is unlikely to be modified or discontinued because of health-related quality of life

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.354, 2002-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valuing health-related quality of life

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 254, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Assessment of Self-reported and Health-related Quality of Life in Patients with Brain Tumours using a Modified Questionnaire

By Miao Y Qiu Y Lin Y Lu X

The Journal of International Medical Research, Vol. 36, Iss. 6, 2008-11 ,pp. : 1279-1286

Field House Publishing

Access to resources Recommend Favorite

Valuing Health-Related Quality of Life: Issues and Controversies

By Dolan P.

PharmacoEconomics, Vol. 15, Iss. 2, 1999-02 ,pp. : 119-127

Adis International

Access to resources Recommend Favorite

Onychomycosis: Health-Related Quality of Life Considerations

By Shaw J.W. Joish V.N. Coons S.J.

PharmacoEconomics, Vol. 20, Iss. 1, 2002-01 ,pp. : 23-36

Adis International

Access to resources Recommend Favorite

By Dennison Cheryl

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 461-476

Adis International

Access to resources Recommend Favorite